{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:25:10Z","timestamp":1761708310823},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,1,31]],"date-time":"2009-01-31T00:00:00Z","timestamp":1233360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s11255-009-9528-y","type":"journal-article","created":{"date-parts":[[2009,1,30]],"date-time":"2009-01-30T02:37:15Z","timestamp":1233283035000},"page":"805-813","source":"Crossref","is-referenced-by-count":17,"title":["Is efficacy of repeated intradetrusor botulinum toxin type\u00a0A (Dysport\u00ae) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity"],"prefix":"10.1007","volume":"41","author":[{"given":"Ibrahim Fathi","family":"Ghalayini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A.","family":"Al-Ghazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad Ali","family":"Elnasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,31]]},"reference":[{"key":"9528_CR1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0302-2838(03)00250-1","volume":"44","author":"T Leippold","year":"2003","unstructured":"Leippold T, Reitz A, Schurch B (2003) Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur Urol 44:165\u2013174. doi: 10.1016\/S0302-2838(03)00250-1","journal-title":"Eur Urol"},{"key":"9528_CR2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","volume":"176","author":"DM Schmid","year":"2006","unstructured":"Schmid DM, Sauermann P, Werner M et al (2006) Experience with 100 cases treated with botulinum-A toxin injections in detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176:177\u2013185. doi: 10.1016\/S0022-5347(06)00590-8","journal-title":"J Urol"},{"key":"9528_CR3","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","volume":"174","author":"R Popat","year":"2005","unstructured":"Popat R, Apostolidis A, Kalsi V, Gonzales G, Fowler CJ, Dasgupta P (2005) Comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 174:984\u2013989. doi: 10.1097\/01.ju.0000169480.43557.31","journal-title":"J Urol"},{"key":"9528_CR4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/nau.20403","volume":"26","author":"IF Ghalayini","year":"2007","unstructured":"Ghalayini IF, Al-Ghazo MA (2007) Intradetrusor injection of botulinum-A toxin in patients with idiopathic and neurogenic detrusor overactivity: urodynamic outcome and patient satisfaction. Neurourol Urodyn 26:531\u2013536. doi: 10.1002\/nau.20403","journal-title":"Neurourol Urodyn"},{"key":"9528_CR5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.eururo.2005.12.002","volume":"49","author":"A Giannantoni","year":"2006","unstructured":"Giannantoni A, Costantini E, Di Stasi SM, Tascini MC, Bini V, Porena M (2006) Botulinum A toxin intravesical injections in treatment of painful bladder syndrome: a pilot study. Eur Urol 49:704\u2013709. doi: 10.1016\/j.eururo.2005.12.002","journal-title":"Eur Urol"},{"key":"9528_CR6","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eururo.2005.12.012","volume":"49","author":"V Kalsi","year":"2006","unstructured":"Kalsi V, Apostolidis A, Popat R, Gonzales G, Fowler CG, Dasgupta P (2006) Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type\u00a0A and correlations with lower urinary tract symptoms and urodynamic changes. Eur Urol 49:528\u2013535. doi: 10.1016\/j.eururo.2005.12.012","journal-title":"Eur Urol"},{"key":"9528_CR7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1464-410X.2006.06192.x","volume":"98","author":"PS Patki","year":"2006","unstructured":"Patki PS, Hamid R, Arumugam K, Shah PJR, Craggs M (2006) Botulinum toxin-type\u00a0A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury. BJU Int 98:77\u201382. doi: 10.1111\/j.1464-410X.2006.06192.x","journal-title":"BJU Int"},{"key":"9528_CR8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","volume":"47","author":"J Grosse","year":"2005","unstructured":"Grosse J, Kramer G, Stohrer M (2005) Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47:653\u2013659. doi: 10.1016\/j.eururo.2004.11.009","journal-title":"Eur Urol"},{"key":"9528_CR9","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1464-410X.2006.06091.x","volume":"97","author":"A Ruffion","year":"2006","unstructured":"Ruffion A, Capelle O, Paparel P, Leriche B, Leriche A, Grise P (2006) What is the optimum dose of type\u00a0A botulinum toxin for treating neurogenic bladder overactivity? BJU Int 97:1030\u20131034. doi: 10.1111\/j.1464-410X.2006.06091.x","journal-title":"BJU Int"},{"key":"9528_CR10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.64.1.6","volume":"64","author":"T Odergren","year":"1998","unstructured":"Odergren T, Hjaltason H, Kaakkola S et al (1998) A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 64:6\u201312. doi: 10.1136\/jnnp.64.1.6","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9528_CR11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nau.10066","volume":"21","author":"W Sch\u00e4fer","year":"2002","unstructured":"Sch\u00e4fer W, Abrams P, Liao L et al (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21:261\u2013274. doi: 10.1002\/nau.10066","journal-title":"Neurourol Urodyn"},{"key":"9528_CR12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164:692\u2013697. doi: 10.1016\/S0022-5347(05)67283-7","journal-title":"J Urol"},{"key":"9528_CR13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.8475382","volume":"260","author":"M Barinaga","year":"1993","unstructured":"Barinaga M (1993) Secrets of secretion revealed. Science 260:487\u2013489. doi: 10.1126\/science.8475382","journal-title":"Science"},{"key":"9528_CR14","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.eururo.2006.01.025","volume":"50","author":"E Comp\u00e9rat","year":"2006","unstructured":"Comp\u00e9rat E, Reitz A, Delcourt A, Capron F, Denys P, Chartier-Kastler E (2006) Histologic features in the urinary bladder wall affected from neurogenic overactivity\u2014a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type\u00a0A. Eur Urol 50:1058\u20131064. doi: 10.1016\/j.eururo.2006.01.025","journal-title":"Eur Urol"},{"key":"9528_CR15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","volume":"174","author":"B Schurch","year":"2005","unstructured":"Schurch B, de Seze M, Denys P et al (2005) Botulinum toxin type\u00a0A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174:196\u2013200. doi: 10.1097\/01.ju.0000162035.73977.1c","journal-title":"J Urol"},{"key":"9528_CR16","first-page":"405","volume":"4","author":"J Grosse","year":"2005","unstructured":"Grosse J, Kramer G, Tong TQT, Stohrer M, Jakse G (2005) Efficacy, dosage and safety of Dysport English botulinum toxin\u00a0A in severe neurogenic detrusor overactivity NDO. Eur Urol Suppl 4:405","journal-title":"Eur Urol Suppl"},{"key":"9528_CR17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.eururo.2007.09.034","volume":"53","author":"G Del Popolo","year":"2008","unstructured":"Del Popolo G, Filocamo MT, Marzi VL et al (2008) Neurogenic detrusor overactivity treated with English botulinum toxin\u00a0A: 8-year experience of one single centre. Eur Urol 53:1013\u20131020. doi: 10.1016\/j.eururo.2007.09.034","journal-title":"Eur Urol"},{"key":"9528_CR18","first-page":"964","volume":"31","author":"JB Holds","year":"1990","unstructured":"Holds JB, Alderson K, Fogg SG, Anderson RL (1990) Motor nerve sprouting in human orbicularis muscle after botulinum A injection. Invest Ophthalmol Vis Sci 31:964\u2013967","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9528_CR19","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0022-5347(01)66376-6","volume":"155","author":"B Schurch","year":"1996","unstructured":"Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB (1996) Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 155:1023\u20131029. doi: 10.1016\/S0022-5347(01)66376-6","journal-title":"J Urol"},{"key":"9528_CR20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","volume":"45","author":"A Reitz","year":"2004","unstructured":"Reitz A, Stohrer M, Kramer G et al (2004) European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45:510\u2013515. doi: 10.1016\/j.eururo.2003.12.004","journal-title":"Eur Urol"},{"key":"9528_CR21","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.eururo.2007.08.052","volume":"52","author":"A Reitz","year":"2007","unstructured":"Reitz A, Denys P, Fermanian C, Schurch B, Comperat E, Chartier-Kastler E (2007) Do repeat intradetrusor botulinum toxin type\u00a0A injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity. Eur Urol 52:1729\u20131735. doi: 10.1016\/j.eururo.2007.08.052","journal-title":"Eur Urol"},{"key":"9528_CR22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","volume":"46","author":"A Haferkamp","year":"2004","unstructured":"Haferkamp A, Schurch B, Reitz A et al (2004) Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type\u00a0A in overactive neurogenic bladder. Eur Urol 46:784\u2013791. doi: 10.1016\/j.eururo.2004.07.011","journal-title":"Eur Urol"},{"key":"9528_CR23","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","volume":"174","author":"A Apostolidis","year":"2005","unstructured":"Apostolidis A, Popat R, Yiangou Y et al (2005) Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174:977\u2013982. doi: 10.1097\/01.ju.0000169481.42259.54 discussion 982\u2013983","journal-title":"J Urol"},{"key":"9528_CR24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","volume":"49","author":"A Apostolidis","year":"2006","unstructured":"Apostolidis A, Dasgupta P, Fowler CJ (2006) Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49:644\u2013650. doi: 10.1016\/j.eururo.2005.12.010","journal-title":"Eur Urol"},{"key":"9528_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/01658109209058127","volume":"12","author":"GE Borodic","year":"1992","unstructured":"Borodic GE, Ferrante R (1992) Effects of repeated botulinum toxin injections on orbicularis oculi muscle. J Clin Neuroophthalmol 12:121\u2013127","journal-title":"J Clin Neuroophthalmol"},{"key":"9528_CR26","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.urology.2006.08.1069","volume":"68","author":"G Karsenty","year":"2006","unstructured":"Karsenty G, Reitz A, Lindemann G, Boy S, Schurch B (2006) Persistence of therapeutic effect after repeated injections of botulinum toxin type\u00a0A to treat incontinence due to neurogenic detrusor overactivity. Urology 68:1193\u20131197. doi: 10.1016\/j.urology.2006.08.1069","journal-title":"Urology"},{"key":"9528_CR27","first-page":"79","volume":"56","author":"A Giannantoni","year":"2004","unstructured":"Giannantoni A, Mearini E, Di Stasi SM et al (2004) New therapeutic options for refractory neurogenic detrusor overactivity. Minerva Urol Nefrol 56:79\u201387","journal-title":"Minerva Urol Nefrol"},{"key":"9528_CR28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0302-2838(03)00136-2","volume":"44","author":"H Schulte-Baukloh","year":"2003","unstructured":"Schulte-Baukloh H, Michael T, Sturzebecher B, Knispel HH (2003) Botulinum-A toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. Eur Urol 44:139\u2013143. doi: 10.1016\/S0302-2838(03)00136-2","journal-title":"Eur Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-009-9528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-009-9528-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-009-9528-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:55:28Z","timestamp":1559375728000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-009-9528-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,31]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["9528"],"URL":"https:\/\/doi.org\/10.1007\/s11255-009-9528-y","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,31]]}}}